Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
SoundThinking
SSTI
$105M
| $446K | ﹤0.01% |
+17,700
| New | +$475K |
|
2402
XBiotech
XBIT
$71.3M
| $441K | ﹤0.01% |
+32,200
| New | +$453K |
|
|
RUBY
2403
DELISTED
Rubius Therapeutics, Inc
RUBY
| $436K | ﹤0.01% |
72,900
+12,000
| +20% | +$70.8K |
|
2404
United States Lime & Minerals
USLM
$3.43B
| $431K | ﹤0.01% |
25,500
+3,500
| +16% | +$54.6K |
|
2405
National CineMedia
NCMI
$249M
| $430K | ﹤0.01% |
14,470
+2,180
| +18% | +$65.5K |
|
2406
Cato Corp
CATO
$66.5M
| $427K | ﹤0.01% |
52,200
+8,100
| +18% | +$79.9K |
|
2407
Verastem
VSTM
$615M
| $426K | ﹤0.01% |
+20,650
| New | +$546K |
|
2408
Greif Class B
GEF.B
$4.27B
| $418K | ﹤0.01% |
10,000
+1,600
| +19% | +$62.7K |
|
2409
MeiraGTx Holdings
MGTX
$1.29B
| $418K | ﹤0.01% |
33,400
+5,400
| +19% | +$75.3K |
|
|
PLYA
2410
DELISTED
Playa Hotels & Resorts
PLYA
| $418K | ﹤0.01% |
115,500
+3,600
| +3% | +$9.75K |
|
2411
Amalgamated Financial
AMAL
$1.53B
| $412K | ﹤0.01% |
32,600
+5,100
| +19% | +$54K |
|
2412
Donegal Group Class A
DGICA
$692M
| $412K | ﹤0.01% |
29,000
+4,800
| +20% | +$68.5K |
|
2413
Greenlight Captial
GLRE
$511M
| $403K | ﹤0.01% |
61,800
+6,400
| +12% | +$41.9K |
|
|
REVG
2414
DELISTED
REV Group
REVG
| $390K | ﹤0.01% |
63,900
+10,200
| +19% | +$54.7K |
|
2415
American Coastal Insurance
ACIC
$465M
| $386K | ﹤0.01% |
49,400
+8,100
| +20% | +$65.7K |
|
|
HMTV
2416
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $377K | ﹤0.01% |
38,400
+3,000
| +8% | +$27.4K |
|
|
LBC
2417
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $376K | ﹤0.01% |
37,600
-400
| -1% | -$3.86K |
|
|
OTRK
2418
DELISTED
Ontrak
OTRK
| $371K | ﹤0.01% |
+167
| New | +$335K |
|
2419
Atlanta Braves Holdings Series A
BATRA
$3.63B
| $370K | ﹤0.01% |
18,422
+1,500
| +9% | +$30.5K |
|
2420
RPC Inc
RES
$1.4B
| $369K | ﹤0.01% |
119,700
-5,100
| -4% | -$15.5K |
|
2421
Merchants Bancorp
MBIN
$2.54B
| $364K | ﹤0.01% |
29,550
+4,500
| +18% | +$47.5K |
|
|
IHC
2422
DELISTED
Independence Holding Company
IHC
| $364K | ﹤0.01% |
11,900
+1,900
| +19% | +$53K |
|
|
HA
2423
DELISTED
Hawaiian Holdings, Inc.
HA
| $358K | ﹤0.01% |
25,509
+3,100
| +14% | +$42.2K |
|
|
LTRPA
2424
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $351K | ﹤0.01% |
164,752
+26,600
| +19% | +$60.6K |
|
2425
Rush Enterprises Class B
RUSHB
$9.29B
| $321K | ﹤0.01% |
20,250
+4,050
| +25% | +$59.9K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.